跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9 条关于
“InnocsAI”
全部
9
临床试验
0
药物
0
机构
0
资讯
9
3个月前
Liminatus Pharma to Acquire InnocsAI in $320 Million Deal, Gaining Next-Generation CAR-T Pipeline for Hematologic and Solid Tumors
去年
Innocan Pharma Secures Indian Patent for Novel Liposomal CBD Pain Treatment Platform
10个月前
Innocan Pharma's Liposomal CBD Platform Shows 28-Day Sustained Release in Preclinical Study
9个月前
InnoCan Pharma's CBD Delivery Platform Achieves 28-Day Sustained Release in Regulatory Study
去年
Innocan Pharma's LPT-CBD Shows Promise in Chronic Pain Treatment, Advances Towards FDA Approval
去年
Innocan Pharma's LPT-CBD Demonstrates Long-Term Pain Relief in Dogs with Osteoarthritis
11个月前
Innocan Pharma Secures Patent for LPT-CBD Technology in Japan's $102 Billion Pharmaceutical Market
6个月前
Innocan Pharma Receives Third Consecutive FDA Fee Waiver for Cannabidiol-Based Pain Treatment in Dogs
去年
Innocan Pharma Advances Liposomal CBD Platform for Chronic Pain as Peer-Reviewed Study Highlights Non-Opioid Alternative